The Recall Desk
HighFDA (Devices)·Z-1371-2013·Announced 2013-06-05

FDA Recalls EZ Breathe Atomizers Due to Choking Hazard

Nephron Pharmaceuticals is recalling EZ Breathe Atomizers because a component may dislodge, creating a choking hazard.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (choking hazard) where no injuries or illnesses have been reported, which aligns with the 'High' severity criteria.

Plain-English summary

Nephron Pharmaceuticals Corp. is recalling 604 units of the EZ Breathe Atomizer, Model # EZ-100. This medical device is used for the delivery of liquid medications for respiratory usage.

The recall was initiated because the "Plate A" component of the atomizer may dislodge. If this occurs, it presents a potential choking hazard to the user.

The affected units were distributed nationwide in the United States, including DC and Puerto Rico, as well as in Guatemala, Poland, Panama, and the United Kingdom. Consumers should stop using the affected atomizers and contact the manufacturer for instructions on how to proceed.

The recalled product

Product
EZ Breathe Atomizer Model # EZ-100. For the delivery of liquid medications for respiratory usage.
Hazard
Affected units
604

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Model # EZ-100 Lots # R2029A
  • R2029B
  • R2039A
  • R2042A
  • R2045A

Distribution

Distributed nationwide across the United States.

The notice also names 34 states specifically:

Part of a larger recall action

This product is one of 3 recalled by Nephron Pharmaceuticals Corp. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →